Clinical Trial Update: PTC Study to Evaluate Ataluren in Combination With Ivacaftor [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating ataluren in combination with ivacaftor for cystic fibrosis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Ivacaftor (ivacaftor)
• ataluren (ataluren)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2020-03-26